Patents by Inventor William SKARNES

William SKARNES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210079387
    Abstract: Modeling human disease in cultured cells requires efficient modification of one or both alleles depending on dominant or recessive inheritance. Editing of single nucleotide variants (SNVs) is particularly challenging because the modified allele contains only one mismatch relative to the target sequence and is subject to re-cleavage and damage by the nuclease. The donor nucleic acids provided herein are, inter alia, useful for editing genome sequences by introducing precise changes in a target site in the presence of the donor sequence and minimizing re-cleavage of the donor nucleic acid by nucleases. By doing so, the compositions and methods provided herein produce modified genomic sequences resistant to nuclease cleavage.
    Type: Application
    Filed: August 21, 2020
    Publication date: March 18, 2021
    Applicant: The Jackson Laboratory
    Inventors: William Skarnes, Justin McDonough, Enrica Pellegrino
  • Publication number: 20210010022
    Abstract: The invention relates to a nucleic acid construct for bi-allelic conditional modification of a target gene and methods of use thereof.
    Type: Application
    Filed: May 26, 2017
    Publication date: January 14, 2021
    Applicants: Cambridge Enterprise Limited, Genome Research Limited
    Inventors: William SKARNES, Bonkyoung KOO, Juergen FINK, Jihoon KIM, Alessandra MERENDA, Camelia Roxana MICSIK, Amanda Maria Hei-Ran ANDERSSON-ROLF